Pharmacology

Action Mechanism of Action Reference
INHIBITOR Plasma kallikrein inhibitor
Primary Target
plasminogen

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pancreatitis 1 D010195 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Psychiatric disorders
30.4
Injury, poisoning and procedural complications
21.28
Renal and urinary disorders
17.02
General disorders and administration site conditions
15.5
Cardiac disorders
6.69
Vascular disorders
4.86
Social circumstances
2.43

Cross References

Resources Reference
CAS NUMBER 9087-70-1
ChEMBL CHEMBL1201619
FDA SRS 04XPW8C0FL
Guide to Pharmacology 6570